Found: 116
Select item for more details and to access through your institution.
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 5, p. 623, doi. 10.1007/s00592-024-02239-8
- By:
- Publication type:
- Article
Corticotrophin-releasing factor receptors within the ventromedial hypothalamus regulate hypoglycemia-induced hormonal counterregulation.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The Response to Hypoglycemia: A Role for the Opioid System?
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2011, v. 96, n. 11, p. 3357, doi. 10.1210/jc.2011-2540
- By:
- Publication type:
- Article
The impact of prior exposure to hypoglycaemia on the inflammatory response to a subsequent hypoglycaemic episode.
- Published in:
- Cardiovascular Diabetology, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12933-023-02095-w
- By:
- Publication type:
- Article
Risk of acute kidney injury and survival in patients treated with Metformin: an observational cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app.
- Published in:
- Diabetologia, 2024, v. 67, n. 10, p. 2160, doi. 10.1007/s00125-024-06233-1
- By:
- Publication type:
- Article
Estimating risk of consequences following hypoglycaemia exposure using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
- Published in:
- Diabetologia, 2024, v. 67, n. 10, p. 2210, doi. 10.1007/s00125-024-06225-1
- By:
- Publication type:
- Article
Trajectories of BMI before and after diagnosis of type 2 diabetes in a real-world population.
- Published in:
- Diabetologia, 2024, v. 67, n. 10, p. 2236, doi. 10.1007/s00125-024-06217-1
- By:
- Publication type:
- Article
Correction: Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Development of a new health-related quality of life measure for people with diabetes who experience hypoglycaemia: the Hypo-RESOLVE QoL.
- Published in:
- Diabetologia, 2024, v. 67, n. 8, p. 1536, doi. 10.1007/s00125-024-06182-9
- By:
- Publication type:
- Article
Risk factors and prediction of hypoglycaemia using the Hypo-RESOLVE cohort: a secondary analysis of pooled data from insulin clinical trials.
- Published in:
- Diabetologia, 2024, v. 67, n. 8, p. 1588, doi. 10.1007/s00125-024-06177-6
- By:
- Publication type:
- Article
Correction to: Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
High intensity interval training as a novel treatment for impaired awareness of hypoglycaemia in people with type 1 diabetes (HIT4HYPOS): a randomised parallel-group study.
- Published in:
- Diabetologia, 2024, v. 67, n. 2, p. 392, doi. 10.1007/s00125-023-06051-x
- By:
- Publication type:
- Article
Disrupted hypothalamic transcriptomics and proteomics in a mouse model of type 2 diabetes exposed to recurrent hypoglycaemia.
- Published in:
- Diabetologia, 2024, v. 67, n. 2, p. 371, doi. 10.1007/s00125-023-06043-x
- By:
- Publication type:
- Article
Chronic hyperglycaemia increases the vulnerability of the hippocampus to oxidative damage induced during post-hypoglycaemic hyperglycaemia in a mouse model of chemically induced type 1 diabetes.
- Published in:
- Diabetologia, 2023, v. 66, n. 7, p. 1340, doi. 10.1007/s00125-023-05907-6
- By:
- Publication type:
- Article
Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.
- Published in:
- Diabetologia, 2022, v. 65, n. 10, p. 1601, doi. 10.1007/s00125-022-05749-8
- By:
- Publication type:
- Article
Correction to: The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Flash monitor initiation is associated with improvements in HbA<sub>1c</sub> levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study.
- Published in:
- Diabetologia, 2022, v. 65, n. 1, p. 159, doi. 10.1007/s00125-021-05578-1
- By:
- Publication type:
- Article
Cold-induced dishabituation in rodents exposed to recurrent hypoglycaemia.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1436, doi. 10.1007/s00125-021-05425-3
- By:
- Publication type:
- Article
Marked improvements in glycaemic outcomes following insulin pump therapy initiation in people with type 1 diabetes: a nationwide observational study in Scotland.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1320, doi. 10.1007/s00125-021-05413-7
- By:
- Publication type:
- Article
The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1309, doi. 10.1007/s00125-021-05394-7
- By:
- Publication type:
- Article
The suitability of patient-reported outcome measures used to assess the impact of hypoglycaemia on quality of life in people with diabetes: a systematic review using COSMIN methods.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1213, doi. 10.1007/s00125-021-05382-x
- By:
- Publication type:
- Article
Consequences of recurrent hypoglycaemia on brain function in diabetes.
- Published in:
- Diabetologia, 2021, v. 64, n. 5, p. 971, doi. 10.1007/s00125-020-05369-0
- By:
- Publication type:
- Article
Hyperinsulinaemic–hypoglycaemic glucose clamps in human research: a systematic review of the literature.
- Published in:
- Diabetologia, 2021, v. 64, n. 4, p. 727, doi. 10.1007/s00125-020-05361-8
- By:
- Publication type:
- Article
Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004–2017.
- Published in:
- Diabetologia, 2020, v. 63, n. 8, p. 1626, doi. 10.1007/s00125-020-05173-w
- By:
- Publication type:
- Article
A randomised controlled study of high intensity exercise as a dishabituating stimulus to improve hypoglycaemia awareness in people with type 1 diabetes: a proof-of-concept study.
- Published in:
- Diabetologia, 2020, v. 63, n. 4, p. 853, doi. 10.1007/s00125-019-05076-5
- By:
- Publication type:
- Article
Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial.
- Published in:
- Diabetologia, 2020, v. 63, n. 3, p. 473, doi. 10.1007/s00125-019-05065-8
- By:
- Publication type:
- Article
Glycaemic control trends in people with type 1 diabetes in Scotland 2004–2016.
- Published in:
- Diabetologia, 2019, v. 62, n. 8, p. 1375, doi. 10.1007/s00125-019-4900-7
- By:
- Publication type:
- Article
The effect of dapagliflozin on glycaemic control and other cardiovascular disease risk factors in type 2 diabetes mellitus: a real-world observational study.
- Published in:
- Diabetologia, 2019, v. 62, n. 4, p. 621, doi. 10.1007/s00125-018-4806-9
- By:
- Publication type:
- Article
SGLT inhibitor adjunct therapy in type 1 diabetes.
- Published in:
- Diabetologia, 2018, v. 61, n. 10, p. 2126, doi. 10.1007/s00125-018-4671-6
- By:
- Publication type:
- Article
Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab.
- Published in:
- Diabetologia, 2018, v. 61, n. 4, p. 743, doi. 10.1007/s00125-018-4548-8
- By:
- Publication type:
- Article
Producing a preference‐based quality of LIFE measure to quantify the impact of HYPOGLYCAEMIA on people living with diabetes: A mixed‐methods research protocol.
- Published in:
- Diabetic Medicine, 2023, v. 40, n. 3, p. 1, doi. 10.1111/dme.15007
- By:
- Publication type:
- Article
Remembrance of things past: The consequences of recurrent hypoglycaemia in diabetes.
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 12, p. 1, doi. 10.1111/dme.14973
- By:
- Publication type:
- Article
Hypo‐METRICS: Hypoglycaemia—MEasurement, ThResholds and ImpaCtS—A multi‐country clinical study to define the optimal threshold and duration of sensor‐detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol
- Published in:
- Diabetic Medicine, 2022, v. 39, n. 9, p. 1, doi. 10.1111/dme.14892
- By:
- Publication type:
- Article
Real‐life hypoglycaemia partially blunts the inflammatory response to experimental hypoglycaemia in people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3696, doi. 10.1111/dom.15712
- By:
- Publication type:
- Article
Association between recent exposure to continuous glucose monitoring‐recorded hypoglycaemia and counterregulatory and symptom responses to subsequent controlled hypoglycaemia in people with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 8, p. 3213, doi. 10.1111/dom.15649
- By:
- Publication type:
- Article
Hypoglycaemia induces a sustained pro‐inflammatory response in people with type 1 diabetes and healthy controls.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3114, doi. 10.1111/dom.15205
- By:
- Publication type:
- Article
Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 3, p. 656, doi. 10.1111/dom.14907
- By:
- Publication type:
- Article
iGlarLixi versus basal plus Rapid‐Acting insulin in adults with type 2 diabetes advancing from basal insulin therapy: The SoliSimplify Real‐World study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. 68, doi. 10.1111/dom.14844
- By:
- Publication type:
- Article
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2391, doi. 10.1111/dom.14825
- By:
- Publication type:
- Article
Improved patient‐reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 12, p. 2364, doi. 10.1111/dom.14822
- By:
- Publication type:
- Article
Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 7, p. 1360, doi. 10.1111/dom.14712
- By:
- Publication type:
- Article
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1221, doi. 10.1111/dom.14354
- By:
- Publication type:
- Article
Glycaemic benefit of iGlarLixi in insulin‐naive type 2 diabetes patients with high HbA1c or those with inadequate glycaemic control on two oral antihyperglycaemic drugs in the LixiLan‐O randomized trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 8, p. 1967, doi. 10.1111/dom.13791
- By:
- Publication type:
- Article
AMP-activated protein kinase ( AMPK) activator A-769662 increases intracellular calcium and ATP release from astrocytes in an AMPK-independent manner.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 997, doi. 10.1111/dom.12912
- By:
- Publication type:
- Article
The genetic association of the transcription factor NPAT with glycemic response to metformin involves regulation of fuel selection.
- Published in:
- PLoS ONE, 2021, v. 16, n. 7, p. 1, doi. 10.1371/journal.pone.0253533
- By:
- Publication type:
- Article
High‐intensity training as a novel treatment for impaired awareness of hypoglycaemia in type 1 diabetes [HIT4HYPOS]: Protocol for a randomized parallel‐group study.
- Published in:
- Endocrinology, Diabetes & Metabolism, 2021, v. 4, n. 1, p. 1, doi. 10.1002/edm2.166
- By:
- Publication type:
- Article
Radix astragali (Huangqi) as a Treatment for Defective Hypoglycemia Counterregulation in Diabetes.
- Published in:
- American Journal of Chinese Medicine, 2010, v. 38, n. 6, p. 1027, doi. 10.1142/S0192415X10008445
- By:
- Publication type:
- Article
5'AMP-activated protein kinase α deficiency enhances stress-induced apoptosis in BHK and PC12 cells.
- Published in:
- Journal of Cellular & Molecular Medicine, 2007, v. 11, n. 2, p. 286, doi. 10.1111/j.1582-4934.2007.00023.x
- By:
- Publication type:
- Article